Open House Pharmaceuticals Budesonide Atc A07Ea06

Deadline: 03 Jun 2027

Germany

Ref. No.: 17469352

EMD:Ref Document

Bid Value: Ref Document

235 Days Left

Open House Medicinal Department Departments Epinephrin Atc C01Ca24

Deadline: 03 Jun 2027

Germany

Ref. No.: 17469346

EMD:Ref Document

Bid Value: Ref Document

235 Days Left

Open House Pharmaceutical Dact Treaties Brinzolamid And Brimonidin Atc S01Ec24

Deadline: 03 Jun 2027

Germany

Ref. No.: 17469337

EMD:Ref Document

Bid Value: Ref Document

235 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Melatonin Exclusively 1Mg And 5Mg Atc N05Ch01 For The Period 01 08 2025 31 2012027

Deadline: 05 Jun 2027

Germany

Ref. No.: 17469294

EMD:Ref Document

Bid Value: Ref Document

237 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Certolizumab Pegol Atc L04Ab05 For The Period 01 08 2025 31 07 2027

Deadline: 05 Jun 2027

Germany

Ref. No.: 17469268

EMD:Ref Document

Bid Value: Ref Document

237 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Iron Iii Derisomalosis Atc B03Ac08 For The Period 01 08 2025 31 07 2027

Deadline: 05 Jun 2027

Germany

Ref. No.: 17469241

EMD:Ref Document

Bid Value: Ref Document

237 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Felbamat Atc N03Ax10 For The Period 01 08 2025 31 07 2027

Deadline: 05 Jun 2027

Germany

Ref. No.: 17469216

EMD:Ref Document

Bid Value: Ref Document

237 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Fluorouracil Atc D11Af05 For The Time 01 08 2025 31 07 2027 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2028

Germany

Ref. No.: 17469170

EMD:Ref Document

Bid Value: Ref Document

603 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Nilotinib Except As A Dispatch In Apple Sauce F D Z 01 8 25 31 7 27 Plus Extension Option 1X12 Month

Deadline: 05 Jun 2028

Germany

Ref. No.: 17469157

EMD:Ref Document

Bid Value: Ref Document

603 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Nomegestrol Estradiol Atc G03Aa14 For The Period 01 08 25 31 07 27 Plus Extension Option 1X12 Month

Deadline: 05 Jun 2028

Germany

Ref. No.: 17469112

EMD:Ref Document

Bid Value: Ref Document

603 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Ponesimod Atc L04Ae04 For The Period 01 08 2025 31 07 2027

Deadline: 05 Jun 2027

Germany

Ref. No.: 17469097

EMD:Ref Document

Bid Value: Ref Document

237 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Colchicin Atc M04Ac01 For The Time 01 08 2025 31 07 2027 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2028

Germany

Ref. No.: 17469092

EMD:Ref Document

Bid Value: Ref Document

603 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Safinamide Atc N04Bd03 For The Period 01 08 2025 31 07 2027 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2028

Germany

Ref. No.: 17469083

EMD:Ref Document

Bid Value: Ref Document

603 Days Left

Open House Pharmaceutical Department Treaties Tolvaptan Except Medicines With Uniform Effects Atc G04Bx21

Deadline: 03 Jun 2027

Germany

Ref. No.: 17468582

EMD:Ref Document

Bid Value: Ref Document

235 Days Left

Anesthesia And Intensive Care Supplies Dps

Deadline: 31 Dec 2030

Finland

Ref. No.: 17466942

EMD:Ref Document

Bid Value: Ref Document

1542 Days Left

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Filter Your Search

FREE Trial plan for all new users!